Keybanc Maintains Overweight on HealthEquity, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Scott Schoenhaus maintains an Overweight rating on HealthEquity (NASDAQ:HQY) and raises the price target from $95 to $100.
June 05, 2024 | 9:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Scott Schoenhaus maintains an Overweight rating on HealthEquity and raises the price target from $95 to $100.
The Overweight rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100